Wistar researchers successfully evaluated a simple intervention that could unlock higher anti-tumour potential in T-cell therapies, a strategy known as "cell-based therapy," which uses specifically tailored T cells to combat cancer.
Researchers developed a tissue-imitating hydrogel model to show that more elastic tissues encourage T cells to develop into effector-like T cells with powerful tumor-killing potential, while more viscous tissues encourage them to develop into memory-like T cells
T cells encounter various mechanical cues in various tissues. In order to demonstrate that more elastic tissues encourage T cells to develop into effector-like T cells with potent tumor-killing potential, while more viscous tissues encourage them to develop into memory-like T cells, research
Washington [US], December 4 (ANI): A new study has found that a novel T cell genetically engineered by University of Arizona Health Sciences researchers is able to target and attack pathogenic T cells that cause Type 1 diabetes, which could lead to new immunotherapy treatments.